Clerc T - Search Results

1

Mechanisms of action in the liver of crilvastatin, a new hydroxymethylglutaryl-coenzyme A reductase inhibitor.

Clerc T, Jomier M, Chautan M, Portugal H, Senft M, Pauli AM, Laruelle C, Morel O, Lafont H, Chanussot F. Clerc T, et al. Eur J Pharmacol. 1993 Apr 22;235(1):59-68. doi: 10.1016/0014-2999(93)90820-8. Eur J Pharmacol. 1993. PMID: 8519281

2

Effect of crilvastatin, a new cholesterol lowering agent, on unesterified LDL-cholesterol metabolism into bile salts by rat isolated hepatocytes.

Clerc T, Sbarra V, Diaconescu N, Lafont H, Jadot G, Laruelle C, Chanussot F. Clerc T, et al. Br J Pharmacol. 1995 Feb;114(3):624-31. doi: 10.1111/j.1476-5381.1995.tb17185.x. Br J Pharmacol. 1995. PMID: 7735689 Free PMC article.

3

Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture.

Clerc T, Sbarra V, Domingo N, Rault JP, Diaconescu N, Moutardier V, Hasselot N, Lafont H, Jadot G, Laruelle C, Chanussot F. Clerc T, et al. Br J Pharmacol. 1996 Aug;118(7):1862-8. doi: 10.1111/j.1476-5381.1996.tb15615.x. Br J Pharmacol. 1996. PMID: 8842455 Free PMC article.

4

Bile salt secretion by hepatocytes incubated with bile salts and liposomes or low density lipoproteins.

Clerc T, Sbarra V, Botta-Fridlund D, Lafont H, Pak-Leung P, Gauthier A, Chanussot F. Clerc T, et al. Life Sci. 1995;56(4):277-86. doi: 10.1016/0024-3205(94)00922-8. Life Sci. 1995. PMID: 7823786

5

Importance of high-density lipoprotein-phosphatidylcholine in secretion of phospholipid and cholesterol in bile.

Portal I, Clerc T, Sbarra V, Portugal H, Pauli AM, Lafont H, Tuchweber B, Yousef I, Chanussot F. Portal I, et al. Among authors: clerc t. Am J Physiol. 1993 Jun;264(6 Pt 1):G1052-6. doi: 10.1152/ajpgi.1993.264.6.G1052. Am J Physiol. 1993. PMID: 8333532

6

Effects of dexamethasone and linoleic acid on hepatic secretion of biliary lipids and anionic polypeptide factor: In vivo and in vitro studies.

Domingo N, Debono E, Reynier MO, Crotte C, Thorin B, Charbonnier M, Clerc T, Grillasca J, Chanussot F, Lafont H. Domingo N, et al. Among authors: clerc t. Digestion. 1999 Nov-Dec;60(6):515-21. doi: 10.1159/000007700. Digestion. 1999. PMID: 10545720

7

Colloidal anticancer drugs bioavailabilities in oral administration models.

Moutardier V, Tosini F, Vlieghe P, Cara L, Delpero JR, Clerc T. Moutardier V, et al. Among authors: clerc t. Int J Pharm. 2003 Jul 9;260(1):23-38. doi: 10.1016/s0378-5173(03)00231-x. Int J Pharm. 2003. PMID: 12818807

8

New 3'-azido-3'-deoxythymidin-5'-yl O-(4-hydroxyalkyl or -alkenyl or -alkylepoxide) carbonate prodrugs: synthesis and anti-HIV evaluation.

Vlieghe P, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Kraus JL. Vlieghe P, et al. Among authors: clerc t. J Med Chem. 2001 Aug 30;44(18):3014-21. doi: 10.1021/jm010863i. J Med Chem. 2001. PMID: 11520210

9

New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.

Vlieghe P, Bihel F, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Chermann JC, Kraus JL. Vlieghe P, et al. Among authors: clerc t. J Med Chem. 2001 Mar 1;44(5):777-86. doi: 10.1021/jm001033s. J Med Chem. 2001. PMID: 11262088

10

Synthesis of new covalently bound kappa-carrageenan-AZT conjugates with improved anti-HIV activities.

Vlieghe P, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Kraus JL. Vlieghe P, et al. Among authors: clerc t. J Med Chem. 2002 Mar 14;45(6):1275-83. doi: 10.1021/jm010969d. J Med Chem. 2002. PMID: 11881996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters